@thelandedeagle... agree on price analysis at FDA EUA.
My price predictions based on big and small players in this antigen testing space...
First, look at the Big Player —Those big players on the top US markets and their P/E Ratios, which are primarily based on their Covid Tests in 2020/2021 FY earnings. (Note: all are Antigun test makers)
- Abbott Laboratories - P/E Ratio: 35.96
- BioRad Laboratories - P/E Ratio: 45.88
- Diasorin - P/E Ratio: 30.7
- Benton Dickensian - P/E Ratio: 35.78
- Qiagen -P/E Ratio: 20.6
- Celltrion - P/E Ratio: 51.55
- OVERALL Medical Products- P/E Ratio: 23.55.
Then look at the small players —- Those players that entered the scene with Therma and the highests values the achieved for nothing… nada... zilch...
- Sona's high of $16+/share ($1B w/ 55M shares out),
- CBDT high of $2.50/share (valuation $832M w/ 333M shares out)
- MIR high of $0.70/share (valuation of $500M w/ 661M shares out)
Now, if Therma sells 2.5M tests per month with a profit of $1.00 to $1.50 profit per test its becomes a $600m - $1B valuation (using the Overall Industry PE Ratio metric of 20.0). And that's only 2.5M tests sold a month in a world of 7B people.
So, I think you are correct on anticipated share price, based on the Big Players, and these Smaller Players in our space.
I'd like to think between $2.50-4.50 per share.
Yesterday or day before, no insurance, no plan for paying for Covid Test in Tornoto it will cost you 40 bucks plus the free and fun time probe.
Were Still winning. imo, any day this week, Friday after hours, fine with that too. GL